Mur de l’institution

University of Maryland Medical Center

Academic flagship hospital of the University of Maryland Medical System (UMMC newsroom).

Annonces

Aucune annonce trouvée.

Vous représentez cette institution ? Contactez-nous pour y publier vos annonces—ou envoyez-nous les détails et nous les ajouterons.

Événements à venir

Aucun événement à venir trouvé.

Vous représentez cette institution ? Contactez-nous pour y publier vos événements—ou envoyez-nous les détails et nous les ajouterons.

Offres d’emploi

Aucune offre d’emploi trouvée.

Vous représentez cette institution ? Contactez-nous pour y publier vos offres—ou envoyez-nous les annonces et nous les ajouterons.

Articles récents

Voir tous les articles

Press Releases 10 Jul 2026

Research at University of Maryland Golisano Children’s Hospital Finds One in Nine Newborns with Down Syndrome Does Not Pass Standard Car Seat Safety Screening Before Hospital Discharge

Approximately one in nine newborns with Down syndrome failed a routine car seat tolerance screening before hospital discharge in a first-of-its-kind study at the University of Maryland Golisano Children’s Hospital (UMGCH).

Research News 12 Jun 2026

Researchers Identify Target with Potential to Improve CAR T-Cell Therapy Response in Patients with Blood Cancers

University of Maryland School of Medicine (UMSOM) researchers have identified a target that may improve the response of CAR T-cell therapy, a treatment for patients with recurrent or difficult-to-treat blood cancers.

Technology & Innovation 03 Jun 2026

University of Maryland Greenebaum Comprehensive Cancer Center is First in Region to Offer Innovative Cell Therapy for Synovial Sarcoma

The University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) is the first in the Maryland, Delaware, Virginia and Washington D.C. region to offer an innovative cell therapy treatment for patients with an advanced type of soft tissue cancer known as synovial sarcoma. This single-infusion T-cell therapy, called TCR-T therapy, involves engineering a patient’s own white blood cells to re

Technology & Innovation 29 Apr 2026

Silver Spring Woman Becomes First Adult Sickle Cell Disease Patient in Maryland to Receive FDA-Approved Gene Therapy

A 41-year-old Silver Spring woman who has endured debilitating pain crises and frequent hospitalizations throughout much of her life as the result of sickle cell disease has been treated at the University of Maryland Medical Center (UMMC) with her own genetically engineered stem cells in an effort to prevent life-threatening complications and achieve a long-term cure.

Press Releases 15 Apr 2026

Large U.S. Trial Finds No Added Benefit from Combination Antibiotic to Prevent Infections After Surgery for Complex Leg Fractures

A large multicenter clinical trial found no benefit to using two antibiotic powders — vancomycin, which targets gram-positive bacteria seen commonly in surgical infections, and tobramycin, which targets gram-negative bacteria that can also cause infection after fracture — during surgery for high-risk leg fractures involving the shin bone.